GlassScriptPhysician profile
Ngozi Odoh
NPI 1376520577
$1,663.74
in general payments reported to CMS, 2019-2025
12 companies · $951 in 2025
The $951 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $351 · 2023: $102 · 2024: $111 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.01 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $379.10 | 2021-2025 | Airsupra |
| Novo Nordisk INC | $371.40 | 2024-2025 | Wegovy, Ozempic |
| Abiomed | $132.97 | 2025 | |
| Gilead Sciences, INC. | $129.64 | 2025 | Livdelzi |
| Neurocrine Biosciences, INC. | $124.99 | 2025 | |
| Axsome Therapeutics, INC. | $117.12 | 2025 | Auvelity |
| Paratek Pharmaceuticals, INC. | $110.06 | 2022 | |
| Genentech USA, INC. | $101.82 | 2023 | Evrysdi |
| Abbvie INC. | $88.53 | 2022 | |
| Genzyme Corporation | $68.34 | 2025 | |
| Astellas Pharma US INC | $24.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ngozi Odoh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.